APSDX | VMGMX | APSDX / VMGMX | |
Total Expense Ratio | 0.83 | 0.07 | 1,186% |
Annual Report Gross Expense Ratio | 0.83 | 0.07 | 1,186% |
Fund Existence | 2 years | 14 years | - |
Gain YTD | -8.910 | -2.984 | 299% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 350M | 28.7B | 1% |
Annual Yield % from dividends | 0.00 | 0.71 | - |
Returns for 1 year | -11.65 | 6.28 | -186% |
Returns for 3 years | N/A | 10.13 | - |
Returns for 5 years | N/A | 104.77 | - |
Returns for 10 years | N/A | 131.89 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VSFCX | 20.50 | 0.31 | +1.54% |
Federated Hermes Clover Small Value C | |||
MUESX | 31.74 | 0.21 | +0.67% |
MFS Blended Research Core Equity R2 | |||
QTERX | 10.61 | 0.02 | +0.19% |
AQR Emerging Multi-Style II R6 | |||
FGDKX | 56.99 | N/A | N/A |
Fidelity Growth Discovery K | |||
GEMWX | 11.53 | N/A | N/A |
Goldman Sachs Emerging Mkt Eq ex. Chn R6 |